Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4377)
All Articles published online
|
Nov 28, 2011 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Liu JB, Qiang FL, Dong J, Cai J, Zhou SH, Shi MX, Chen KP, Hu ZB. Plasma DNA methylation of Wnt antagonists predicts recurrence of esophageal squamous cell carcinoma. World J Gastroenterol 2011; 17(44): 4917-4921 [PMID: 22171134 DOI: 10.3748/wjg.v17.i44.4917] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i44/4917.htm |
| Number | Citing Articles |
| 1 |
Jian-Liang Chen, Zhi-Xiong Lin, Yun-Sheng Qin, Yu-Qi She, Yun Chen, Chen Chen, Guo-Dong Qiu, Jie-Ting Zheng, Zhong-Lin Chen, Shu-Yao Zhang. Overexpression of long noncoding RNA LINC01419 in esophageal squamous cell carcinoma and its relation to the sensitivity to 5-fluorouracil by mediating GSTP1 methylation. Therapeutic Advances in Medical Oncology 2019; 11 doi: 10.1177/1758835919838958
|
| 2 |
Ling-Yu Chu, Yu-Hui Peng, Xue-Fen Weng, Jian-Jun Xie, Yi-Wei Xu. Blood-based biomarkers for early detection of esophageal squamous cell carcinoma. World Journal of Gastroenterology 2020; 26(15): 1708-1725 doi: 10.3748/wjg.v26.i15.1708
|
| 3 |
Yasushi Toh, Akinori Egashira, Manabu Yamamoto. Epigenetic alterations and their clinical implications in esophageal squamous cell carcinoma. General Thoracic and Cardiovascular Surgery 2013; 61(5): 262 doi: 10.1007/s11748-013-0235-3
|
| 4 |
Naoki Katase, Kenichi Nagano, Shuichi Fujita. DKK3 expression and function in head and neck squamous cell carcinoma and other cancers. Journal of Oral Biosciences 2020; 62(1): 9 doi: 10.1016/j.job.2020.01.008
|
| 5 |
Razvan Iacob, Matei Mandea, Speranta Iacob, Catalina Pietrosanu, Doru Paul, Razvan Hainarosie, Cristian Gheorghe. Liquid Biopsy in Squamous Cell Carcinoma of the Esophagus and of the Head and Neck. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.827297
|
| 6 |
Dong Jiang, Zhenglei He, Chenji Wang, Yinghui Zhou, Fang Li, Weilin Pu, Xueqing Zhang, Xulong Feng, Meng Zhang, Xinyue Yecheng, Yunyun Xu, Li Jin, Shicheng Guo, Jiucun Wang, Minghua Wang. Epigenetic silencing of ZNF132 mediated by methylation-sensitive Sp1 binding promotes cancer progression in esophageal squamous cell carcinoma. Cell Death & Disease 2018; 10(1) doi: 10.1038/s41419-018-1236-z
|
| 7 |
Inuk Zandvakili, Konstantinos N. Lazaridis. Cell-free DNA testing: future applications in gastroenterology and hepatology. Therapeutic Advances in Gastroenterology 2019; 12 doi: 10.1177/1756284819841896
|
| 8 |
CHANG LIU, NAN LI, HENG LU, ZHENGKAI WANG, CHUNYAN CHEN, LIN WU, JIONG LIU, YOUKE LU, FANGYU WANG. Circulating SFRP1 promoter methylation status in gastric adenocarcinoma and esophageal square cell carcinoma. Biomedical Reports 2015; 3(1): 123 doi: 10.3892/br.2014.388
|
| 9 |
Chengliang Yang, Sining Shen, Xiaoli Zheng, Ke Ye, Hong Ge, Yanan Sun, Yufei Lu. Long non‐coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4. The FASEB Journal 2020; 34(5): 6055 doi: 10.1096/fj.201900731RR
|
| 10 |
Shahin Ramazi, Maedeh Dadzadi, Zahra Sahafnejad, Abdollah Allahverdi. Epigenetic regulation in lung cancer. MedComm 2023; 4(6) doi: 10.1002/mco2.401
|
| 11 |
Abeer A. Alsofyani, Rawiah A. Alsiary, Alaa Samkari, Baraa T. Alhaj-Hussain, Jalaluddin Azam Khan, Jaudah Al-Maghrabi, Aisha Elaimi, Mohammed H. Al-Qahtani, Adel M. Abuzenadah, Ashraf Dallol. Prognostic potential of KLOTHO and SFRP1 promoter methylation in head and neck squamous cell carcinoma. Journal of Applied Genetics 2017; 58(4): 459 doi: 10.1007/s13353-017-0404-7
|
| 12 |
Jarosław Paluszczak, Dawid Hemmerling, Magdalena Kostrzewska‐Poczekaj, Małgorzata Jarmuż‐Szymczak, Reidar Grenman, Małgorzata Wierzbicka, Wanda Baer‐Dubowska. Frequent hypermethylation of WNT pathway genes in laryngeal squamous cell carcinomas. Journal of Oral Pathology & Medicine 2014; 43(9): 652 doi: 10.1111/jop.12178
|
| 13 |
H Wang, X Wang, R Hu, W Yang, A Liao, C Zhao, J Zhang, Z Liu. Methylation of SFRP5 is related to multidrug resistance in leukemia cells. Cancer Gene Therapy 2014; 21(2): 83 doi: 10.1038/cgt.2013.87
|
| 14 |
Feng Li, Jing Zhang, Chao Ma, Ziqian Wang, Yinhua Li, Jimin Zhao, Kangdong Liu. Targeting Epigenetic Aberrations in Esophageal Squamous Cell Carcinoma. Current Pharmacology Reports 2020; 6(6): 415 doi: 10.1007/s40495-020-00238-1
|
| 15 |
Silvia Rodrigues Jardim, Lucila Marieta Perrotta de Souza, Heitor Siffert Pereira de Souza. The Rise of Gastrointestinal Cancers as a Global Phenomenon: Unhealthy Behavior or Progress?. International Journal of Environmental Research and Public Health 2023; 20(4): 3640 doi: 10.3390/ijerph20043640
|
| 16 |
Lei Dong, Yumei Li, Xiaoyu Song, Caiyu Sun, Xicheng Song. SFRP1 mediates cancer-associated fibroblasts to suppress cancer cell proliferation and migration in head and neck squamous cell carcinoma. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12907-1
|
| 17 |
Rattaya Amornpisutt, Siriporn Proungvitaya, Patcharee Jearanaikoon, Temduang Limpaiboon. DNA methylation level of OPCML and SFRP1: a potential diagnostic biomarker of cholangiocarcinoma. Tumor Biology 2015; 36(7): 4973 doi: 10.1007/s13277-015-3147-2
|
| 18 |
Hua-Zhong Huang, Yi-Fa Yin, Wen-Jun Wan, Dan Xia, Rui Wang, Xue-Min Shen. Up-regulation of microRNA-136 induces apoptosis and radiosensitivity of esophageal squamous cell carcinoma cells by inhibiting the expression of MUC1. Experimental and Molecular Pathology 2019; 110: 104278 doi: 10.1016/j.yexmp.2019.104278
|
| 19 |
Sarwat Fatima, John M Luk, Ronnie TP Poon, Nikki P Lee. Dysregulated expression of dickkopfs for potential detection of hepatocellular carcinoma. Expert Review of Molecular Diagnostics 2014; 14(5): 535 doi: 10.1586/14737159.2014.915747
|
| 20 |
Victoria Sherwood, Irene M. Leigh. WNT Signaling in Cutaneous Squamous Cell Carcinoma: A Future Treatment Strategy?. Journal of Investigative Dermatology 2016; 136(9): 1760 doi: 10.1016/j.jid.2016.05.108
|
| 21 |
Andrew M. Kaz, William M. Grady. Epigenetic biomarkers in esophageal cancer. Cancer Letters 2014; 342(2): 193 doi: 10.1016/j.canlet.2012.02.036
|
| 22 |
Lehang Lin, Xu Cheng, Dong Yin. Aberrant DNA Methylation in Esophageal Squamous Cell Carcinoma: Biological and Clinical Implications. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.549850
|
| 23 |
Zhe Jin, Xiaojing Zhang, Xinmin Fan. Epigenetic Cancer Therapy. 2015; : 351 doi: 10.1016/B978-0-12-800206-3.00016-1
|
| 24 |
Chun Chen, Yifei Zhang, Yupeng Liu, Lei Hang, Jun Yang. Expression of Tumor Suppressor SFRP1 Predicts Biological Behaviors and Prognosis: A Potential Target for Oral Squamous Cell Carcinoma. Biomolecules 2022; 12(8): 1034 doi: 10.3390/biom12081034
|
| 25 |
Peng Ye, Chang-Fa Qu, Xue-Lin Hu. Impact of IGF-1, IGF-1R, and IGFBP-3 promoter methylation on the risk and prognosis of esophageal carcinoma. Tumor Biology 2016; 37(5): 6893 doi: 10.1007/s13277-015-4489-5
|
| 26 |
S.-G. Shiah, Y.-S. Shieh, J.-Y. Chang. The Role of Wnt Signaling in Squamous Cell Carcinoma. Journal of Dental Research 2016; 95(2): 129 doi: 10.1177/0022034515613507
|
| 27 |
Jun Yu, Yang Xie, Mengying Li, Fenfang Zhou, Zhenyang Zhong, Yuting Liu, Feng Wang, Jian Qi. Association between SFRP promoter hypermethylation and different types of cancer: A systematic review and meta‑analysis. Oncology Letters 2019; doi: 10.3892/ol.2019.10709
|
| 28 |
Xiaoying Chen, Haochang Hu, Jing Liu, Yong Yang, Guili Liu, Xiuru Ying, Yingmin Chen, Bin Li, Cong Ye, Dongping Wu, Shiwei Duan. FOXF2 promoter methylation is associated with prognosis in esophageal squamous cell carcinoma. Tumor Biology 2017; 39(2): 101042831769223 doi: 10.1177/1010428317692230
|
| 29 |
Naoki Katase, Shin-Ichiro Nishimatsu, Akira Yamauchi, Masahiro Yamamura, Kumiko Terada, Masumi Itadani, Naoko Okada, Nur Mohammad Monsur Hassan, Hitoshi Nagatsuka, Tohru Ikeda, Tsutomu Nohno, Shuichi Fujita. DKK3 Overexpression Increases the Malignant Properties of Head and Neck Squamous Cell Carcinoma Cells. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2018; 26(1): 45 doi: 10.3727/096504017X14926874596386
|
| 30 |
Zainul Hasanali, August Stuart, Nelson Yee, Kamal Sharma, Elliot Epner. The Epigenetics of Gastrointestinal Malignancies. Current Colorectal Cancer Reports 2012; 8(4): 254 doi: 10.1007/s11888-012-0147-0
|
| 31 |
Shunlin Liu, Xiaoying Chen, Ruhua Chen, Jinzhi Wang, Guoliang Zhu, Jianzhong Jiang, Hongwei Wang, Shiwei Duan, Jianan Huang. Diagnostic role of Wnt pathway gene promoter methylation in non small cell lung cancer. Oncotarget 2017; 8(22): 36354 doi: 10.18632/oncotarget.16754
|
| 32 |
Kirti Gondkar, Krishna Patel, Geeta V. Patil Okaly, Bipin Nair, Akhilesh Pandey, Harsha Gowda, Prashant Kumar. Dickkopf Homolog 3 (DKK3) Acts as a Potential Tumor Suppressor in Gallbladder Cancer. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01121
|
| 33 |
Leila Hamzehzadeh, Michele Caraglia, Stephen L. Atkin, Amirhossein Sahebkar. Dickkopf homolog 3 (DKK3): A candidate for detection and treatment of cancers?. Journal of Cellular Physiology 2018; 233(6): 4595 doi: 10.1002/jcp.26313
|
| 34 |
Zainab Al Shareef, Mai Nidal Asad Ershaid, Rula Mudhafar, Sameh S. M. Soliman, Robert M. Kypta. Dickkopf-3: An Update on a Potential Regulator of the Tumor Microenvironment. Cancers 2022; 14(23): 5822 doi: 10.3390/cancers14235822
|
| 35 |
Zhuo Wang, Tingting Zhao, Shihui Zhang, Junkai Wang, Yunyun Chen, Hongzhou Zhao, Yaxin Yang, Songlin Shi, Qiang Chen, Kuancan Liu. The Wnt signaling pathway in tumorigenesis, pharmacological targets, and drug development for cancer therapy. Biomarker Research 2021; 9(1) doi: 10.1186/s40364-021-00323-7
|
| 36 |
Patrick S Plum, Elfriede Bollschweiler, Arnulf H Hölscher, Ute Warnecke-Eberz. Novel diagnostic and prognostic biomarkers in esophageal cancer. Expert Opinion on Medical Diagnostics 2013; 7(6): 557 doi: 10.1517/17530059.2013.843526
|
| 37 |
Takayoshi Kishino, Tohru Niwa, Satoshi Yamashita, Takamasa Takahashi, Hidetsugu Nakazato, Takeshi Nakajima, Hiroyasu Igaki, Yuji Tachimori, Yasuyuki Suzuki, Toshikazu Ushijima. Integrated analysis of DNA methylation and mutations in esophageal squamous cell carcinoma. Molecular Carcinogenesis 2016; 55(12): 2077 doi: 10.1002/mc.22452
|
| 38 |
Yi Wang, Xiuguang Qin, Jieqing Wu, Bo Qi, Yipeng Tao, Wenju Wang, Fulei Liu, Hanchen Li, Baosheng Zhao, Qing-Yi Wei. Association of Promoter Methylation of RUNX3 Gene with the Development of Esophageal Cancer: A Meta Analysis. PLoS ONE 2014; 9(9): e107598 doi: 10.1371/journal.pone.0107598
|